Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction
Authors
Keywords
<sup>18</sup>F-galacto-RGD, <sup>68</sup>Ga-NODAGA-RGD, <sup>68</sup>Ga-TRAP(RGD)<sub>3</sub>, PET, Myocardial infarction
Journal
EJNMMI Research
Volume 3, Issue 1, Pages 38
Publisher
Springer Nature
Online
2013-05-12
DOI
10.1186/2191-219x-3-38
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Focal Adhesion Kinase Activation in Cardiomyocytes Protects the Heart From Ischemia/Reperfusion Injury
- (2012) Zhaokang Cheng et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2
- (2012) Haokao Gao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular Imaging of Early v 3 Integrin Expression Predicts Long-Term Left-Ventricle Remodeling After Myocardial Infarction in Rats
- (2012) H. M. Sherif et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-NODAGA-RGD is a suitable substitute for 18F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process
- (2012) Karolin Pohle et al. NUCLEAR MEDICINE AND BIOLOGY
- Be spoilt for choice with radiolabelled RGD peptides: Preclinical evaluation of 68Ga-TRAP(RGD)3
- (2012) Johannes Notni et al. NUCLEAR MEDICINE AND BIOLOGY
- Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
- (2012) Johannes Notni et al. EJNMMI Research
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- TRAP, a Powerful and Versatile Framework for Gallium-68 Radiopharmaceuticals
- (2011) Johannes Notni et al. CHEMISTRY-A EUROPEAN JOURNAL
- Complexation of Metal Ions with TRAP (1,4,7-Triazacyclononane Phosphinic Acid) Ligands and 1,4,7-Triazacyclononane-1,4,7-triacetic Acid: Phosphinate-Containing Ligands as Unique Chelators for Trivalent Gallium
- (2011) Jakub Šimeček et al. INORGANIC CHEMISTRY
- Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled V 3-Integrin and V 5-Integrin Imaging Agent
- (2011) M. R. Battle et al. JOURNAL OF NUCLEAR MEDICINE
- Repair After Myocardial Infarction, Between Fantasy and Reality
- (2011) Elisa A. Liehn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- In vivo molecular imaging of myocardial angiogenesis using the αvβ3 integrin-targeted tracer 99mTc-RAFT-RGD
- (2010) Julien Dimastromatteo et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Ligands for Mapping αvβ3-Integrin Expression in Vivo
- (2009) Margret Schottelius et al. ACCOUNTS OF CHEMICAL RESEARCH
- β3 Integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy
- (2009) Rebecca K. Johnston et al. FASEB JOURNAL
- Assessment of v 3 integrin expression after myocardial infarction by positron emission tomography
- (2008) T. Higuchi et al. CARDIOVASCULAR RESEARCH
- 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression
- (2008) Zi-Bo Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular Imaging of Interstitial Alterations in Remodeling Myocardium After Myocardial Infarction
- (2008) Susanne W.M. van den Borne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started